Latest News about NVS
Recent news which mentions NVS
10 Health Care Stocks Whale Activity In Today's Session
November 28, 2022
From Benzinga
3 Biotech Stocks Smart Investors Should Be Buying Up Now
November 24, 2022
From InvestorPlace
Novartis' Malaria Treatment Candidate To Move Forward With Phase 3 Development Next Year
November 23, 2022
Tickers
NVS
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 22, 2022
From Benzinga
First Patients Dosed in Phase I/II Trial of Enlivex's Off-the-Shelf Cell Therapy Candidate, AllocetraTM
November 22, 2022
From Benzinga
TEVA Stock Alert: What to Know About Teva Pharmaceuticals’ New CEO
November 21, 2022
From InvestorPlace
2 Top Biotech Stocks to Buy Right Now
November 19, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 17, 2022
From Benzinga
BioNTech Plans To Set Up Singapore Based mRNA Plant By End Of 2023
November 14, 2022
From Benzinga
Should Income Investors Buy This High-Yielding Dividend Stock?
November 13, 2022
Tickers
NVS
From Motley Fool
2 Biotech Stocks That Could Make You Richer
November 04, 2022
From Motley Fool
After FDA, European Agency Limits Use Of Certain JAK Inhibitors Amid Safety Concerns
October 31, 2022
From Benzinga
3 High-Yielding Dividend Stocks That You Can Buy and Hold Forever
October 27, 2022
From Motley Fool
Twitter Considers Crypto Wallet, Geopolitical Woes To Keep Tesla Shares Volatile, Juul Explores Possible Bailout: Top Stories Tuesday, Oct. 25
October 25, 2022
From Benzinga
From Motley Fool
US Stock Futures Down; Big Tech Earnings In Focus
October 25, 2022
From Benzinga
Novartis Clocks 4% Drop In Quarterly Sales, Once Again Perks Up Sandoz Earnings Outlook
October 25, 2022
Tickers
NVS
From Benzinga
Earnings Scheduled For October 25, 2022
October 25, 2022
From Benzinga
Tickers
NVS
From MarketWatch
A Look Into Healthcare Sector Value Stocks
October 24, 2022
From Benzinga
Novartis Experimental Drug Shows Meaningful Superiority Over Previous Treatment In Rare Blood Disorder
October 24, 2022
Tickers
NVS
From Benzinga
Novartis hemoglobinuria trial meets two primary endpoints
October 24, 2022
Tickers
NVS
From MarketWatch
Precision Medicine Could Get Even More Precise With Allarity Therapeutics' "Next-Generation" Diagnostics Platform
October 17, 2022
From Benzinga
Biden Asked OPEC+ To Delay Output Decision, Elon Musk Faces Federal Probe Over Twitter Deal, Netflix Ad-Supported Plan: Top Stories Friday, Oct. 14
October 14, 2022
From Benzinga
Novartis Fails To Prevent Generic Competition For Its Blockbuster Multiple Sclerosis Drug
October 14, 2022
From Benzinga
From Benzinga
2 Cathie Wood Stocks That Are Beating the Market This Year
October 07, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.